Emit II Plus Opiate Assay, Model OSR9B229

FDA 510(k) K011289 · Syva Co., Dade Behring, Inc.

Substantially Equivalent

510(k) numberK011289

Submission

Device name
Emit II Plus Opiate Assay, Model OSR9B229
Applicant
Syva Co., Dade Behring, Inc.
San Jose, CA, US
Received
April 27, 2001
Decision date
May 15, 2001
Decision
Substantially Equivalent (SESE)
Type
Special 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
DJG – Enzyme Immunoassay, Opiates
Device class
Class II (moderate risk)
Regulation
21 CFR 862.3650
Specialty
Clinical Toxicology

Other 510(k)s with product code DJG

510(k)DeviceApplicantDecision
K252684Labcorp Fentanyl Urine Visual TestDJG · Traditional Medtox Diagnostics, Inc.01/29/2026SE
K250741Evidence MultiSTAT DOA Urine MultiPlexDJG · Traditional Randox Laboratories Limited01/23/2026SE
K253082LZI Buprenorphine II Enzyme ImmunoassayDJG · Traditional Lin-Zhi International, Inc.01/16/2026SE
K252520SEFRIA™ Hydrocodone Oral FluidDJG · Traditional Immunalysis Corporation09/11/2025SE
K251972Healgen® AccuFluor Fentanyl Fluorescence Immunoassay (FIA)Test Kit - Qualitative…DJG · Traditional Healgen Scientific,, LLC08/15/2025SE
K251634LZI Fentanyl III Enzyme ImmunoassayDJG · Special Lin-Zhi International, Inc.06/18/2025SE
K240124BioSieve™ Fentanyl FIA Test Kit; BioSieve™ ToxiSmart FIA ReaderDJG · Traditional Vivachek Biotech (Hangzhou) Co., Ltd.06/14/2024SE
K240698Dochek® Multi-Drug Urine Test Dipcard Rx; Dochek® Multi-Drug Urine Test DipcardDJG · Traditional Guangzhou Decheng Biotechnology Co., Ltd.05/10/2024SE
K231904Rapid Fentanyl (FYL) Test Strip, Rapid Fentanyl (FYL) Test DipcardDJG · Traditional Co-Innovation Biotech Co., Ltd.03/08/2024SE
K232228Multi-drug Urine Test Cup, Multi-drug Urine Test Dip Card, Accurature Multi-drug Urine…DJG · Traditional Shanghai Accurature Diagnostics Co., Ltd.02/23/2024SE

More from Shanghai Accurature Diagnostics Co., Ltd.

510(k)DeviceDecision
K011920Emit 2000 Digoxin Assay, Model OSR4H229KXT · Special 07/02/2001SE
K011620Emit 2000 N-Acetylprocainamide Assay, Model OSR4N229LAN · Special 06/18/2001SE
K011605Emit 2000 Quinidine Assay, Model OSR4Q229LBZ · Special 06/12/2001SE
K011300Emit II Plus Cannabinoid Assay, Model OSR9N229LDJ · Special 05/17/2001SE
K011306Emit II Plus Benzodiazepine Assay, Model 0SR9F229JXM · Special 05/16/2001SE
K011161Modification to the Emit II Plus Phencyclidine Assay, Model OSR9J229LCM · Special 05/15/2001SE
K011166Modification to Emit 2000 Theophylline Assay, Model Osr 4P229KLS · Special 05/10/2001SE
K011164Modification to the Emit II Plus Methaqualone Assay, Model OSR9Q229KXS · Special 05/10/2001SE
K011163Modification to the Emit II Plus Propoxyphene Assay, Model OSR9G229JXN · Special 05/10/2001SE
K011162Modification to the Emit II Plus Cocaine Metabolite AssayDIO · Special 05/02/2001SE

Questions and answers

When was Emit II Plus Opiate Assay, Model OSR9B229 cleared by the FDA?

Emit II Plus Opiate Assay, Model OSR9B229 (K011289) received a 510(k) decision of Substantially Equivalent on May 15, 2001, 18 days after the submission was received.

What is the product code of K011289?

The FDA product code is DJG – Enzyme Immunoassay, Opiates, a Class II (moderate risk) device regulated under 21 CFR 862.3650.